The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Predicting selective drug targets in cancer through metabolic networks
Open accessAbstract
The interest in studying metabolic alterations in cancer and their potential role as novel targets for therapy has been rejuvenated in recent years. Here, we report the development of the first genome-scale network model of cancer metabolism, validated by correctly identifying genes essential for cellular proliferation in cancer cell lines. The model predicts 52 cytostatic drug targets, of which 40% are targeted by known, approved or experimental anticancer drugs, and the rest are new. It further predicts combinations of synthetic lethal drug targets, whose synergy is validated using available drug efficacy and gene expression measurements across the NCI-60 cancer cell line collection. Finally, potential selective treatments for specific cancers that depend on cancer type-specific downregulation of gene expression and somatic mutations are compiled.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Genome-scale models of microbial cells: evaluating the consequences of constraints
Price, N. D., Reed, J. L., & Palsson, B. Ø. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1023 · Cited by 1,023
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Metabolic network structure determines key aspects of functionality and regulation
Stelling, J., Klamt, S., Bettenbrock, K., Schuster, S., & Gilles, E. D. (2002) · Nature · doi:10.1038/nature01166 · Cited by 802
Integrating high-throughput and computational data elucidates bacterial networks
Covert, M. W., Knight, E. M., Reed, J. L., Herrgard, M. J., & Palsson, B. O. (2004) · Nature · doi:10.1038/nature02456 · Cited by 792
The National Cancer Institute: cancer drug discovery and development program.
Grever, M. R., Schepartz, S. A., & Chabner, B. A. (1992) · PubMed · Cited by 722
Network-based prediction of human tissue-specific metabolism
Shlomi, T., Cabili, M. N., Herrgård, M. J., Palsson, B. Ø., & Ruppin, E. (2008) · Nature Biotechnology · doi:10.1038/nbt.1487 · Cited by 637
Self-citationForbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp995 · Cited by 573
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 547
The implications of human metabolic network topology for disease comorbidity
Lee, D.-S., Park, J., Kay, K. A., Christakis, N. A., Oltvai, Z. N., & Barabási, A.-L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802208105 · Cited by 495
The Edinburgh human metabolic network reconstruction and its functional analysis
Ma, H., Sorokin, A., Mazein, A., Selkov, A., Selkov, E., Demin, O., & Goryanin, I. (2007) · Molecular Systems Biology · doi:10.1038/msb4100177 · Cited by 435
Fan, T. W., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., & Miller, D. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-41 · Cited by 434
Partridge, A. H., Burstein, H. J., & Winer, E. P. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003451 · Cited by 426
Genome-scale microbial in silico models: the constraints-based approach
Price, N. D., Papin, J. A., Schilling, C. H., & Palsson, B. O. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(03)00030-1 · Cited by 400
Jerby, L., Shlomi, T., & Ruppin, E. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.56 · Cited by 368
Self-citationLee, J. K., Havaleshko, D. M., Cho, H., Weinstein, J. N., Kaldjian, E. P., Karpovich, J., Grimshaw, A., & Theodorescu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610292104 · Cited by 316
Shlomi, T., Eisenberg, Y., Sharan, R., & Ruppin, E. (2007) · Molecular Systems Biology · doi:10.1038/msb4100141 · Cited by 254
Self-citationMetabolic transformation in cancer
Tennant, D. A., Duran, R. V., Boulahbel, H., & Gottlieb, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp070 · Cited by 225
Self-citationInParanoid 6: eukaryotic ortholog clusters with inparalogs
Berglund, A.-C., Sjolund, E., Ostlund, G., & Sonnhammer, E. L. L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1020 · Cited by 221
Yogev, O., Yogev, O., Singer, E., Shaulian, E., Goldberg, M., Fox, T. D., & Pines, O. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000328 · Cited by 220 · cited 2×
“…Biology 2011 5 cancers associated with FH mutations such as leiomyoma, leiomyosarcoma or renal cell carcinoma (Futreal et al, 2004) (though notably, the tumor suppressor function of FH was recently shown to go beyond its TCA cycle activity, contributing to DNA damage response; Yogev et al, 2010).”
Chang, R. L., Xie, L., Xie, L., Bourne, P. E., & Palsson, B. Ø. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000938 · Cited by 204
Plasticity of genetic interactions in metabolic networks of yeast
Harrison, R., Papp, B., Pál, C., Oliver, S. G., & Delneri, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607153104 · Cited by 195
Multiple knockout analysis of genetic robustness in the yeast metabolic network
Deutscher, D., Meilijson, I., Kupiec, M., & Ruppin, E. (2006) · Nature Genetics · doi:10.1038/ng1856 · Cited by 191
Self-citationInborn and acquired metabolic defects in cancer
Frezza, C., Pollard, P. J., & Gottlieb, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0728-4 · Cited by 149
Self-citationLarge-Scale Evaluation of In Silico Gene Deletions in Saccharomyces cerevisiae
Förster, J., Famili, I., Palsson, B. Ø., & Nielsen, J. (2003) · OMICS A Journal of Integrative Biology · doi:10.1089/153623103322246584 · Cited by 142
Guillermet‐Guibert, J., Davenne, L., Pchejetski, D., Saint‐Laurent, N., Brizuela, L., Guilbeau‐Frugier, C., Delisle, M., Cuvillier, O., Susini, C., & Bousquet, C. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1096 · Cited by 141
Evolutionary plasticity of genetic interaction networks
Tischler, J., Lehner, B., & Fraser, A. G. (2008) · Nature Genetics · doi:10.1038/ng.114 · Cited by 131
Cancer proteomics: from biomarker discovery to signal pathway profiling.
Bichsel, V. E., Liotta, L. A., & Petricoin, E. (2001) · PubMed · Cited by 127
Increased Choline Kinase Activity and Elevated Phosphocholine Levels in Human Colon Cancer†
NAKAGAMI, K., Uchida, T., Ohwada, S., Koibuchi, Y., Suda, Y., Sekine, T., & Morishita, Y. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00764.x · Cited by 124
Defining the Importance of Phosphatidylserine Synthase-1 (PSS1)
Arikketh, D., Nelson, R., & Vance, J. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800714200 · Cited by 93
Althaus, C. L., & de Boer, R. J. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.4 · Cited by 85
Physiological consequences of disruption of mammalian phospholipid biosynthetic genes
Vance, D. E., & Vance, J. E. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800048-jlr200 · Cited by 81
Li, L., Zhou, X., Ching, W., & Wang, P. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-501 · Cited by 59
Rosenfeld, H., & Roberts, J. (1981) · PubMed · Cited by 41
An Atlas on genes and chromosomes in oncology and haematology.
Huret, J. L., Senon, S., Bernheim, A., & Dessen, P. (2004) · PubMed · Cited by 28
Increased choline Kinase activity and elevated phosphocholine levels in human colon cancer
中神, 克. (2000) · Medical Entomology and Zoology · doi:10.11501/3171966 · Cited by 11
Cited by
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
Stincone, A., Prigione, A., Cramer, T., Wamelink, M. M. C., Campbell, K., Cheung, E., Olin‐Sandoval, V., Grüning, N., Krüger, A., Tauqeer Alam, M., et al. (2015) · Biological Reviews · doi:10.1111/brv.12140 · Cited by 1,576
Quantitative flux analysis reveals folate-dependent NADPH production
Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., & Rabinowitz, J. D. (2014) · Nature · doi:10.1038/nature13236 · Cited by 1,114
Self-citationCombinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
A community-driven global reconstruction of human metabolism
Thiele, I., Swainston, N., Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., Haraldsdottir, H., Mo, M. L., Rolfsson, O., Stobbe, M. D., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2488 · Cited by 1,019
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Metadata
- Authors
- Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T.
- Venue
- Molecular Systems Biology
- Published
- 2011-01
- Volume
- 7
- Issue
- 1
- Pages
- 501-501
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W2099787654
- Cited by
- 476
- References
- 47
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.